Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Tough assignment

IDP Education
3:27pm
March 2, 2025
IEL reported 1H25 underlying EBIT of A$92.7m, down 41.6% on pcp. 1H25 came in slightly above our expectation, however well below consensus. Weaker than expected Student Placement (SP) volumes (-27% on pcp) and SP margins (-400bps) were slightly offset by tighter overhead control (-9% on pcp). IELTs volumes were flat HOH (-24% on pcp). A significant decline in Indian volumes (-55%) were partially offset by growth elsewhere. The direct China IELTS testing entry has been delayed and pushed out by ~6-months. Policy uncertainty across major jurisdictions continues. The UK is showing green shoots post-election; however Australia and Canada elections take place CY25. We continue to expect FY25 to be the ‘trough’ year for student volumes and IEL, however note the trough has deepened and the recovery timing relies on clearer policy. The timing and shape of the recovery is unclear, with more clarity on policy unlikely until election cycles conclude (AUS, CAD). On a medium to long-term basis, we see value in the business however note patience is required given certain/improved policy settings is a required catalyst.

Outlook remains soft

Endeavour Group
3:27pm
March 2, 2025
EDV’s 1H25 result was below our expectations but largely in line with Visible Alpha consensus. Retail EBIT (-15%) was impacted by an ongoing subdued consumer environment and supply chain disruptions in VIC, while Hotels delivered modest growth (+1%). EDV also advised that Chairman Ari Mervis will be appointed as Executive Chairman and replace Steve Donohue as CEO and Managing Director from 17 March 2025 as the search for a permanent replacement continues. We adjust FY25/26/27F group EBIT by -4%/2%/0% and our target price decreases to $4.35 (from $4.54 previously). In our view, EDV is a good business and ongoing investments into data, digital and productivity will support growth over the long-term. In the short term however, the sales environment remains soft with customers likely to remain value-conscious. With cost inflation (including One Endeavour costs) still elevated and a permanent CEO yet to be appointed, we see limited upside in EDV’s share price over the next 12 months and maintain our Hold rating.

Headwinds abating

Vysarn
3:27pm
February 28, 2025
VYS delivered a robust result considering the well-documented utilisation headwinds which plagued the Industrial business (EBIT -50% YoY). Both Technologies and Advisory performed strongly, with EBIT up +71% and +116% YoY, respectively. Not only are the headwinds in Industrial abating as demand for rigs continues to improve, but, going forward, the group will no longer be so susceptible to swings in the Hydro business as a result of recent acquisitions. The outlook commentary was upbeat. The company effectively guided to ~$15m PBT for FY25 and talked up the prospects of the Kariyarra resource as potentially one of “state and national significance”. We move our PBT forecast upwards to align with guidance, however, based on an earnings bridge, we think there’s risk to the upside. We increase our PBT forecasts by +3% in FY25 and +5-7% in FY26-27. Our price target increases to 58cps (from 55cps)

I like big boats and I cannot lie

Experience Co
3:27pm
February 28, 2025
EXP’s 1H25 materially beat MorgansF. Whilst Skydive’s top line remains fairly subdued given the slow recovery of inbound tourists and cost of living pressures, strong earnings growth was delivered by Adventure Experiences reflecting increased volumes and revenue per customer and strong margin expansion. The 2H25 has had a strong start with Jan EBITDA up 32% on the pcp. We have made material upgrades to our forecasts reflecting EXP’s strong margin outcome. Trading on a FY26F EV/EBITDA of 4.8x and a FCF yield of ~10%, EXP is far too cheap especially given its strong growth outlook (~14% FY25-28F EBITDA CAGR).

Health Insurance business the standout.

Medibank
3:27pm
February 28, 2025
MPL’s 1H25 Underlying NPAT (A$298m) was 6% above company compiled consensus (A$282m). This was a strong MPL result overall, highlighted by a robust performance in its key Health Insurance franchise. We upgrade our MPL FY25F/FY26F operating profit forecasts by 3%-4%, with more muted changes at EPS (-1%/+1%). Our MPL price target is raised to A$4.52 (previously A$4.11) on our earnings changes and a valuation roll-forward. Whilst this was a good result, we see MPL trading on 19x PE as fair value at current levels. HOLD.

Accelerating flows sees earnings growth continue

Regal Partners
3:27pm
February 28, 2025
Given Dec-24 FUM and CY24 performance fees were pre-released, the result was largely in line with expectations. That aside, it is not lost on us the scale to which this business has grown over the past 12 months - normalised NPAT +200% (vs pcp), FUM +64% (+25% excluding Merricks and Argyle acquisitions), dividends up 180%. Momentum in net inflows (+$1.9bn or +310% on pcp) will likely see continued growth in both base management fees and performance fees (96% of net flows performance fee-eligible), while the 30% of flows from offshore investors extends the reach of RPL’s distribution and FUM aspirations. Trading at a PER of 14x (CY24), with a strong balance sheet and capacity to continue growing FUM, we retain our Add rating with a price target of $4.50/sh (previously $4.40/sh).

1H25 earnings: Making a strong point

BETR Entertainment
3:27pm
February 28, 2025
BBT has maintained strong performance over the past six months, benefiting from a successful Spring Racing Period and the migration of betr customers onto its platform. The company delivered positive EBITDA of $1.7m and remains on track to achieve an EBITDA-positive result for the full year. BBT expressed disappointment over PBH’s Board rejecting its initial cash and scrip offer in favor of MIXI’s all-cash deal. BBT says it plans to release further details on its value proposition in the coming days, which based on limited data available we believe could be in excess of 70% EPS accretive. We have not included any deal in our numbers. Following the result, our FY26 EBITDA estimate decreases nominally to $5.8m. We retain an Add rating, with our $0.47 price target unchanged.

Marketing set to ramp up in the second half

Airtasker
3:27pm
February 28, 2025
Airtasker’s (ART) 1H25 result was largely pre-released, and the majority of key headline metrics known. The operating performance was broadly per our expectations, with growth seen across all regions. A ramp up in media inventory deployment in the 2H (for the northern hemisphere peak) should assist in its offshore marketplaces maintaining its robust growth momentum. Our revenue forecasts are largely unchanged, and we make only marginal changes to our marketing expense assumptions in this note given management guidance. Our price target remains unchanged at A$0.56. Add maintained.

The elephant in the room

Clinuvel Pharmaceuticals
3:27pm
February 27, 2025
CUV has reported its 1H25 result which lands in-line with consensus and our forecasts on revenues, but ahead in NPAT however the beat was driven by a surprise wind-down of material costs to practically zero. A low-quality beat here and we would expect there to be a true-up over the coming halves. The elephant in the room continues to grow, and management opts to defy investor concerns around its lazy balance sheet, with cash now sitting ~33% of the market valuation. We downgrade our target price to A$15 p/s (from A$17 p/s) and we move the recommendation to a Speculative Buy, noting increased risk around competitive threats. Traders may find an opportunity down here, but equally prepared to wait until several investor concerns are addressed and external threats unfold.

Post balance pick up

Objective Corporation
3:27pm
February 27, 2025
OCL’s 1H25 result, was broadly in-line with our forecasts with NPAT of $17.0m consistent with MorgF, however ARR growth of 10% in 1H25 was softer than MorgF (13%) however this appears to have been made up with a further $4.5m of wins over the last 2 month, 1H25 EBITDA margins were also better than feared, however previously flagged investment in US sales is expected to land in 2H25, which will likely see FY25 margins consistent with 39% in 1H25. Management reiterated confidence in its 15% Net ARR growth target, pointing to building momentum across each of its business line into 2H25 (vs to MorgF 13.3%). We reduce our EBITDA forecasts by -2% across FY25-FY27F, this sees our blended DCF/EV/EBITDA based price target revised to $16.75ps (from $17.80ps), our Hold rating is retained.

News & Insights

Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more
The U.S. and China, through negotiations led by the Chinese Deputy Premier and U.S. Treasury Secretary Scott Bessent, agreed to a 90-day tariff reduction from over 125% to 30% and 10% respectively

US and Chinese actions had led to an unintended embargo of trade between the world’s two largest economies.

In recent days there has been discussion of the temporary “cease fire” in the tariff war between the US and China.

The situation was that both countries had levied tariffs on each other more than 125%. This had led to a mutual embargo of trade between the two world is two largest economies. Then as a result of negotiation between the Deputy Premier of China and US Treasury Secretary Scott Bessent both China and the US agreed to a 90 day pause in “hostilities” where both sides agreed to reduce the US tariff on the China to 30 percent and the Chinese tariff on the US to 10%.

Some suggested that this meant that “China had won” others suggested that the “US had won.” To us this really suggests that both parties were playing in a different game. The was a game in which both sides had won.

To understand why this is the case we must understand a little of the theory of this type of competition. Economists usually use discuss competition in terms of markets where millions of people are involved. In such a case we find a solution by finding the intersection of supply and demand which model the exchange between vast numbers of people.

But here we are ware talking of a competition where only two parties are involved.

When exceedingly small numbers like this are involved, we find the solution to the competition by what is called “Game Theory.”

In this game there are only two players. One is called China, and the other is called the US. Game theory teaches us that are there three different types of games. The first is a zero-sum game. In this game there two sides are competing over a fixed amount of product. Again, this is called " A zero sum game “. Either one party gets a bigger share of the total sum at stake and the other side gets less. This zero-sum game is how most of the Media views the competition between the US and China.

A second form is a decreasing sum game. An example of this is a war. Some of the total amount that is fought over is destroyed in the process. Usually both sides will wind up worse than when they started.

Then there is a third form. This form is called an ‘increasing sum game.’ This is where both sides cooperate so that the total sum in the game grows because of this cooperation. We think that what happened in the US and China negotiation was an increasing sum game.

As Scott Bessent said at the Saudi Investment Forum in Riyadh soon after the agreement was signed, “both sides came with a clear agenda with shared interests and great mutual respect.”

He said, “after the weekend, we now have a mechanism to avoid escalation like we had before. We both agreed to bring the tariff levels down by 115% which I think is very productive because where we were with 145% and 125% was an unintended embargo. That is not healthy for the two largest economies in the world.”

He went on, “when President Trump began the tariff program, we had a plan, we had a process. What we did not have with the Chinese was a mechanism. The Vice Premier and I now call this the ‘Geneva mechanism’”.

Both sides cooperated to make both sides better off. Bessent added “what we do not want, and both sides agreed, is a generalised decoupling between the two largest economies in the world. What we want is the US to decouple in strategic industries, medicine, semiconductors, other strategic areas. As to other countries; we have had very productive discussions with Japan, South Korea, Indonesia, Taiwan, Thailand. Europe may have collective action problems with the French wanting one thing and the Italians wanting a different thing. but I am confident that with Europe, we will arrive at a satisfactory conclusion.

We have a very good framework. I think we can proceed from here.”

What we think we can see here is that the United States and China have cooperated to both become better off. This is what we call an increasing sum game.

They will continue their negotiation using that approach. This will do much to allay the concerns that so many had about the effect of these new tariffs.

Read more